Overview

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin

Status:
Completed
Trial end date:
2020-09-07
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the effect of nilotinib on the pharmacokinetics and pharmacodynamics of metformin in healthy male adults
Phase:
Phase 1
Details
Lead Sponsor:
Hyewon Chung
Treatments:
Metformin